![Carlos Gallardo Piqué](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos Gallardo Piqué
Directeur Général chez
ALMIRALL, S.A.
Profil
Carlos Gallardo Piqué is the founder of CG Health Ventures SL, which was founded in 2015.
He is currently the Chairman & Chief Executive Officer at Almirall SA since 2014 and an Investment Advisor at Nina Capital SGEIC SA. Previously, he worked as a Venture Partner at Ysios Capital Partners SGEIC SA from 2014 to 2018 and as the General Manager at Almirall Ltd. from 2008 to 2013.
Mr. Gallardo Piqué completed his undergraduate degree at the Polytechnic University of Catalonia and holds an MBA from Stanford Graduate School of Business.
Postes actifs de Carlos Gallardo Piqué
| Sociétés | Poste | Début |
|---|---|---|
| ALMIRALL, S.A. | Directeur Général | 02/11/2022 |
CG Health Ventures SL
 CG Health Ventures SL Investment ManagersFinance CG Health Ventures invests in companies located in Spain. The firm targets companies operating in the field of Health IT, Digital Health and Genomics. They provide financing for early stage capital requirements. | Fondateur | 01/01/2015 |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Consultant / Advisor | - |
Anciens postes connus de Carlos Gallardo Piqué
| Sociétés | Poste | Fin |
|---|---|---|
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 30/04/2018 |
Almirall Ltd.
 Almirall Ltd. Pharmaceuticals: OtherHealth Technology Develops, produces and markets R&D medicines | Directeur Général | 01/07/2013 |
Formation de Carlos Gallardo Piqué
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Polytechnic University of Catalonia
 Polytechnic University of Catalonia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
Almirall Ltd.
Almirall Ltd. Pharmaceuticals: OtherHealth Technology Develops, produces and markets R&D medicines | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Health Ventures SL
CG Health Ventures SL Investment ManagersFinance CG Health Ventures invests in companies located in Spain. The firm targets companies operating in the field of Health IT, Digital Health and Genomics. They provide financing for early stage capital requirements. | Finance |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Finance |
